Serum antibody response to polysaccharides in children with recurrent respiratory tract infections

dc.creatorLópez Yap, Alberto
dc.creatorAbdelnour Vásquez, Arturo
dc.creatorLomonte, Bruno
dc.creatorPorras Madrigal, Oscar
dc.date.accessioned2017-12-20T13:49:17Z
dc.date.accessioned2019-04-25T15:54:41Z
dc.date.available2017-12-20T13:49:17Z
dc.date.available2019-04-25T15:54:41Z
dc.date.created2017-12-20T13:49:17Z
dc.date.issued2001
dc.identifierhttp://cvi.asm.org/content/8/5/1012
dc.identifier1556-6811
dc.identifier1556-679X
dc.identifierhttp://hdl.handle.net/10669/73708
dc.identifier10.1128/CDLI.8.5.1012-1014.2001
dc.identifier11527819
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/2389851
dc.description.abstractWe evaluated children (15-months old and older) with recurrent upper respiratory tract infections and normal levels of immunoglobulins in serum for specific polysaccharide immunodeficiency using an enzyme-linked immunosorbent assay method. Results showed that of 12 patients vaccinated with Act-HIB vaccine, one did not develop specific antibodies to Haemophilus influenzae type b, demonstrating that such immunodeficiency is present in Costa Rican children.
dc.languageen_US
dc.rightshttp://creativecommons.org/publicdomain/zero/1.0/
dc.rightsCC0 1.0 Universal
dc.sourceClinical and Diagnostic Laboratory Immunology 8(5), 1012-1014 (2001)
dc.subjectimmunodeficiency
dc.titleSerum antibody response to polysaccharides in children with recurrent respiratory tract infections
dc.typeArtículos de revistas
dc.typeArtículo científico


Este ítem pertenece a la siguiente institución